Most Popular Documents

See which documents other people are reading and reviewing most often. The list is updated on a regular basis to give you the most current information.

Displaying Most Popular Documents

220 Items

Position Statements for the Implementation of Oncology Biosimilars from the pan-Canadian Clinical Operations Working Group

Document Status: Current
Version: 1

Aug 2019

Kadcyla® Trastuzumab Emtansine Safety Reminder

Document Status: Current
ID: GL-C50-15

Jun 2014

Person-Centred Virtual Cancer Care Clinical Guidance

Document Status: Current
Version: 2

Jan 2022

Systemic Therapy for Recurrent, Metastatic, or Persistent Cervical Cancer

Document Status: Current
ID: 4-20
Version: 2

Nov 2014

Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Document Status: Current
ID: GL SCT-8

Oct 2017

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Pandemic Planning Clinical Guideline for Patients with Cancer

Document Status: Current
Version: 2

Dec 2021

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Document Status: Current
ID: GL-C50-21

Jul 2015

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Document Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

Radiation Oncology Peer Review Guidance Document

Document Status: Current
ID: GL-C50-10
Version: 1

May 2021

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Document Status: Current
ID: GL END 2-31

Jul 2018

Gallium-68 PET Imaging in Neuroendocrine Tumours

Document Status: Current
ID: PET 19
Version: n/a

Nov 2018